Media

https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otc-etbi/

March 25, 2019 by admin

Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)

Read more

Eastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply

March 19, 2019 by admin

Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse

Read more

EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships

January 30, 2019 by admin

EastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre

Read more

EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019

December 19, 2018 by admin

Eastgate Biotech Corp.appointed key consultants Saul A. Mashaal, PhmB, MBA and Munaf Ali, PhD to assist in regulatory matters and manufacturing of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients.

Read more

EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives

November 19, 2018 by admin

EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

Read more

CORRECTED LINK: CEO Anna Gluskin's interview with Uptick Newswire on 17 October 2018

October 22, 2018 by admin

Eastgate Biotech Corp. CEO Anna Gluskin's interview with Uptick Newswire on October 17, 2018

Read more

CEO Anna Gluskin, Interview with Uptick Network on October 17, 2018

October 22, 2018 by admin

Anna Gluskin's interview with Uptick Network on October 17, 2018

Read more

CEO Anna Gluskin's interview-Uptick network 17Oct2018

October 22, 2018 by admin

Anna Gluskin, CEO, Eastgate Biotech Corp. Interview on Uptick Network on 17Oct.2018

Read more

EastGate Biotech Signs Definitive Investment

August 27, 2018 by admin

EastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution Non-Dilutive Investment and Product License includes licensing fee and development costs

Read more

EastGate Biotech Provides Update on investment from Genluiching Mining Corporation

July 24, 2018 by admin

EastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement.

Read more
RSS Icon